Results 101 to 110 of about 316,033 (212)

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials

open access: yes, 2012
Background: In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with peginterferon and ribavirin (PR) significantly increased sustained virologic response (SVR) rates compared with PR alone.
Bambang Adiwijaya   +79 more
core   +1 more source

Alpha-fetoprotein in chronic hepatitis C

open access: yesJournal of the Formosan Medical Association, 2011
Ching-Sheng Hsu
doaj   +1 more source

Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]

open access: yes, 2008
Patients with chronic hepatitis B virus (HBV) infection have a substantial risk of reactivation and jaundice following the use of immunosuppressant therapy.
Pol, Stanislas   +7 more
core  

Treatment Response to Sofosbuvir and Ribavirin in Chronic Hepatitis C Patients and Comparison of Naive and Treatment Experienced Patients

open access: yesJournal of Rawalpindi Medical College, 2018
Background: Sofosbuvir is on the world organization’s list of essential medicines, the most effective and safe medicines needed in health system. It plays a special role in treatment of chronic hepatitis C and offers many advantages due to its high ...
Muhammad Ikhlaq   +3 more
doaj  

FREQUENCY OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

open access: yesJournal of University Medical & Dental College, 2015
: BACKGROUND: In developing countries, Diabetes Mellitus and Hepatitis C virus infection are major public health problems. A range of extra-hepatic manifestation such as artharlgia, thyroiditis and Type 2 Diabetes Mellitus are associated with Hepatitis C
Sumera Riaz   +2 more
doaj  

Lifetime medical costs of chronic hepatitis C in the United States. [PDF]

open access: yesBMC Health Serv Res
Abimbola TO   +4 more
europepmc   +1 more source

Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C. [PDF]

open access: yesInfect Dis Ther
Lee JW   +11 more
europepmc   +1 more source

Steatotic liver disease in patients with chronic hepatitis C. [PDF]

open access: yesWorld J Hepatol
Janczura J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy